Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 17, 2021

Novartis’ prostate cancer drug secures FDA breakthrough designation

Novartis has secured breakthrough therapy designation from the US Food and Drug Administration (FDA) for Lu-PSMA-617 to treat metastatic castration-resistant prostate cancer (mCRPC).

Continue
Novartis is developing new radioligand therapy for metastatic prostate cancer. Credit: Novartis AG.
May 13, 2021

CD&R agrees to acquire UDG Healthcare for $3.7bn

UDG provide healthcare advisory, communications, commercial, clinical services. Credit: Arek Socha from Pixabay
May 12, 2021

Lilly, MiNA Therapeutics partner to develop new drug candidates

Lilly will be responsible for activities related to preclinical and clinical development of candidates. Credit: Momoneymoproblemz.

Contracts

June 15, 2021

GSK, iTeos Therapeutics to co-develop and co-commercialise cancer drug

The collaboration will see GSK and iTeos share responsibility and costs for the global development of EOS-448. Credit: Colin Behrens from Pixabay

BMS signs cancer therapy deal worth $1.5bn with Agenus

Dr. Reddy’s signs license deal for anti-BCMA CAR-T PRG1801 in India

AstraZeneca to deliver 500,000 more doses of AZD7442 to US

Deals

Deals June 3, 2021

MorphoSys agrees to acquire Constellation Pharmaceuticals for $1.7bn

Pharmaceutical Business Review

Prestige Consumer Healthcare to acquire Akorn’s brands for $230m

Carlyle Group to acquire pharma firm Vectura for $1.4bn

GSK to sell stake in respiratory partner Innoviva for $392m

Popular

  1. Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns
  2. EMA’s CHMP approves Moderna’s new Covid-19 vaccine manufacturing site in France
  3. Ocugen plans to seek full approval for Covaxin in US
  4. Merck to supply 1.7 million courses of molnupiravir to US
  5. Indivior, Aelis Farma partner to advance treatment for cannabis use disorder

PRESS RELEASES

Learn with NSF – Check Our Training Schedule and New Self-Paced eLearning
Learn with NSF – Check Our Training Schedule and New Self-Paced eLearning
Gerresheimer in North America: Clinical Supply Program for Gx RTF vials is part of a comprehensive service offering
Gerresheimer in North America: Clinical Supply Program for Gx RTF vials is part of a comprehensive service offering
EcoLine Ensures the Most Sustainable Packaging Solution
EcoLine Ensures the Most Sustainable Packaging Solution
How Denny Bros over-coding labels help healthcare professionals
How Denny Bros over-coding labels help healthcare professionals
Gerresheimer AG is part of the United Nations Global Compact
Gerresheimer AG is part of the United Nations Global Compact

Suppliers

Whitepapers

Specialised Drug Development Services
Specialised Drug Development Services
Maxims for Early Phase Trials
Maxims for Early Phase Trials
GxP Regulated Industry Assessments of SoftMax Pro Software
GxP Regulated Industry Assessments of SoftMax Pro Software